Jack Hoppin

Company: Ratio Therapeutics

Job title: Chief Executive Officer

Seminars:

Panel Discussion: Investigating Attributes of a Prime Radiopharmaceutical Target to Match the Properties of a Radioactive Drug 9:00 am

Considering receptor density, expression levels and radiosensitive tissues Analyzing alpha vs beta emitter target requirements for optimal strategy Assessing stromal targeting such as FAP or internalized targetsRead more

day: Conference Day One